Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by Cheng-Pang Hou
Risk Factors Associated With Ineligibility of Adjuvant Cisplatin-Based Chemotherapy After Nephroureterectomy
Drug Design, Development and Therapy
Drug Discovery
Pharmacology
Pharmaceutical Science
Related publications
Cerebral Infarction After Cisplatin-Based Chemotherapy.
Postgraduate Medical Journal
Medicine
Factors Associated With Delayed Time to Adjuvant Chemotherapy in Stage Iii Colon Cancer
Current Oncology
Oncology
Endovascular Treatment of Acute Abdominal Aortic Thrombosis After Cisplatin-Based Chemotherapy
Journal of Vascular Medicine & Surgery
Adjuvant Bidirectional Chemotherapy With Intraperitoneal Pemetrexed Combined With Intravenous Cisplatin for Diffuse Malignant Peritoneal Mesothelioma
Gastroenterology Research and Practice
Hepatology
Gastroenterology
Relapse-Associated microRNA in Gastric Cancer Patients After S-1 Adjuvant Chemotherapy
Oncology Reports
Medicine
Cancer Research
Oncology
Risk Factors Associated With Delayed Haemorrhage After Pancreatic Resection
HPB
Hepatology
Gastroenterology
Identification of Risk Factors Associated With Postoperative Acute Kidney Injury After Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy: A Retrospective Study
International Journal of Hyperthermia
Medicine
Cancer Research
Radiological
Physiology
Ultrasound Technology
Survival Analysis of Adjuvant Chemotherapy With S-1 Plus Cisplatin for Stage III Gastric Cancer
Gastric Cancer
Cancer Research
Medicine
Oncology
Gastroenterology
The Factors Reducing Relative Dose Intensity of Cisplatin and Vinorelbine as Adjuvant Chemotherapy in Patients With Non-Small Cell Lung Cancer
Oncomedicine
